Divergent expression and function of glucocorticoid receptor β in human monocytes and T cells
- 3 February 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 79 (4) , 818-827
- https://doi.org/10.1189/jlb.0805466
Abstract
Glucocorticoid (GC) insensitivity is a significant problem in the treatment of immune-mediated diseases. The current study examined whether T cells and monocytes differed in their response to GC and the potential molecular basis for their variation in response to steroids. Functional studies revealed that dexamethasone (DEX) inhibited phorbol 12-myristate 13-acetate/ionomycin-induced tumor necrosis factor α and interleukin-6 production to a significantly lesser extent in monocytes than T cells. In parallel, a significantly longer period of time was required for DEX to induce the steroid-responsive gene, mitogen-activated protein kinase phosphatase-1 (MKP-1), in human monocytes as compared with T cells. It is interesting that such differences were not observed between murine T cells and monocytes. GC receptor β (GCRβ) is a splicing variant of the classic GCR, GCRα, which functions as a dominant-negative inhibitor of GCRα in humans, not mice (as mice do not express GCRβ mRNA as a result of a difference in the murine GCR 9b exon sequence). It was found that human monocytes had a significantly higher level of GCRβ than T cells. Furthermore, GCRβ was found in the cytoplasm and nucleus of monocytes, and GCRβ was localized to the nucleus of T cells. This raised the possibility that GCRβ in the cytoplasm could affect GCRα cellular shuttling in response to DEX. Indeed, we found that DEX-induced nuclear translocation of GCRα was decreased in monocytes as compared with T cells. Specific RNA silencing of GCRβ in human monocytes resulted in enhanced steroid-induced GCRα transactivation and transrepression. Our data suggest that GCRβ contributes to variation in the GC responses of monocytes versus T cells.Keywords
Funding Information
- NIH (AR41256, 5R21AR051634)
- NIH
- NIAID (N01 AI40029, N01 AI40030)
- General Clinical Research Center (MO1 RR00051)
- Division of Research Resources
- Edelstein Family Chair in Pediatric Allergy and Immunology
- University of Colorado Cancer Center
This publication has 43 references indexed in Scilit:
- Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal LocalizationJournal of Molecular Biology, 2005
- Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacyNature Biotechnology, 2004
- Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD MacrophagesThe Journal of Experimental Medicine, 2004
- Update on glucocorticoid action and resistanceJournal of Allergy and Clinical Immunology, 2003
- Increased number of glucocorticoid receptor-β–expressing cells in the airways in fatal asthmaJournal of Allergy and Clinical Immunology, 2000
- Long‐term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitisClinical and Experimental Allergy, 1999
- Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor βThe Journal of Experimental Medicine, 1997
- Absence of Glucocorticoid Receptor-β in MicePublished by Elsevier ,1997
- Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapyAllergy, 1997
- Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans.Journal of Clinical Investigation, 1995